DNAJC5 and malaria: These findings support vaccine and mAb strategies involving multiple Plasmodium pre-erythrocytic-stage antigens and argue that efforts to develop a long-lasting, infection-blocking malaria intervention would greatly benefit from identifying non-CSP antibody targets that can enhance CSP-elicited protection.